Related Experiment Video
Updated: Jan 6, 2026

07:08
Efficient Mammalian Cell Expression and Single-step Purification of Extracellular Glycoproteins for Crystallization
Published on: December 23, 2015
14.2K
Two Simple Methods for Optimizing the Production of "Difficult-to-Express" GnRH-DFF40 Chimeric Protein
Mahdi Barazesh1, Zohreh Mostafavipour2,3, Soudabeh Kavousipour1
1Department of Biotechnology, School of Advanced Medical Science and Technologies, Shiraz University of Medical Sciences, Shiraz, IR Iran.
Advanced Pharmaceutical Bulletin
|October 9, 2019
Summary
This study optimized recombinant protein production for GnRH-DFF40, a potential cancer therapy. The autoinduction method significantly enhanced soluble protein yields in E. coli, overcoming expression challenges.
Area of Science:
- Biotechnology
- Molecular Biology
- Protein Expression
Background:
- GnRH-DFF40 is a promising immunotoxin for treating GnRHR-overexpressing cancers.
- Challenges exist in producing soluble and functional GnRH-DFF40 in Escherichia coli.
Purpose of the Study:
- To develop optimized conditions for high-yield production and purification of GnRH-DFF40.
- To compare high cell density induction (HCDI) and autoinduction methods (AIM) for protein expression.
Main Methods:
- A synthetic, codon-optimized GnRH-DFF40 gene was cloned into a pET28a plasmid.
- Investigated HCDI and AIM, optimizing AIM parameters like carbon sources, incubation, temperature, and plasmid stability.
- Evaluated protein production at different temperatures and pH levels, assessing plasmid stability.
Main Results:
- Both HCDI and AIM yielded significant soluble GnRH-DFF40.
- AIM produced approximately 1.5-fold higher cell density and protein yields than HCDI.
- Optimized AIM achieved a high yield of 528.3 mg/L, with 25°C being optimal for production.
Conclusions:
- Optimized high-density expression methods, particularly AIM, significantly enhance soluble protein yields for difficult-to-express proteins like GnRH-DFF40.
- These methods offer reproducible improvements over conventional expression techniques.
- Successful production of GnRH-DFF40 paves the way for its therapeutic applications.

